U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776405) titled 'A Double-Blinded Study on Rapid and Sustained Pain Relief Topical Cannabidiol for Plantar Fasciitis' on Aug. 17.
Brief Summary: This prospective, double-blinded, placebo-controlled study evaluates the efficacy of a 6000 mg transdermal CBD cream in adults with plantar fasciitis. Fifty participants will apply either CBD or placebo once daily for one month.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Plantar Fasciitis
Intervention:
DRUG: transdermal CBD cream (Tolcylen(R), Marlinz Pharma)
The active product is the study CBD cream supplied by the manufacturer. Dosing is three pumps per application which deliv...